TIDMVENN

RNS Number : 5057L

Venn Life Sciences Holdings PLC

12 January 2016

Venn Life Sciences Holdings Plc

("Venn" or the "Company")

Contracts worth EUR 3.4m signed with US Biotech

Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that they have signed new contracts worth over EUR3.4m with a leading US based Biotechnology client.

These contracts are extensions of an existing Phase II programme. The work will commence immediately and run until the end of 2017 in multiple US and European sites.

Speaking about the agreement, Venn CEO, Tony Richardson stated: "During 2015, I commented that executing our work to a consistent high standard would bring significant rewards and I am delighted to be able to show the concrete evidence of this. This is the second extension of what is a complex international programme and this endorsement is well deserved by our team. It is particularly pleasing to win this business at the commencement of the new year. 2015 was a year of significant growth at Venn and new business wins of this magnitude will enable us to continue expanding our business."

Enquiries:

 
 Venn Life Sciences Holdings Plc                                  www.vennlifesciences.com 
 Tony Richardson, Chief Executive Officer                             Tel: +353 154 99 341 
 Jonathan Hartshorn, Chief Financial Officer                          Tel: +353 153 93 269 
 Orla McGuinness, Marketing Manager                                   Tel: +353 153 93 269 
 
 Zeus Capital (Nominated Adviser and Joint                       Tel: +44 (0) 20 3829 5000 
  Broker) 
 Andrew Jones / Phil Walker 
 Dominic Wilson / Alex Davis 
 
 Hybridan LLP (Joint-Broker) 
 Claire Louise Noyce                                                    Tel: 020 3764 2341 
 
 Walbrook PR Ltd                                 Tel: 020 7933 8787 or venn@walbrookpr.com 
 Lianne Cawthorne                                                       Mob: 07584 391 303

About Venn Life Sciences Limited: Venn Life Sciences is a Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK, Ireland and Europe wide representation - Venn Life Sciences specialises in rapid deployment and management of multisite projects, across all phases. Venn Life Sciences also has an innovation division - Innovenn - focused primarily on breakthrough development opportunities in Skin Science.

For more information about the Company, please visit: www.vennlifesciences.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCQFLFFQFFEBBD

(END) Dow Jones Newswires

January 12, 2016 02:00 ET (07:00 GMT)

Hvivo (LSE:HVO)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Hvivo Charts.
Hvivo (LSE:HVO)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Hvivo Charts.